Our Corporate Group represents public and private entities, as well as high net-worth individuals, in all aspects of their transactional and governance needs.  We have multi-disciplinary teams with experienced lawyers to meet our clients’ demanding specific requirements.

The Corporate Group represents clients in numerous industries, with particular strength in the technology, healthcare, life science, software, manufacturing, environmental solutions and waste management industries.  We serve our clients in a full range of domestic and cross‑border matters, including mergers and acquisitions; corporate and corporate governance; entity formation; securities; private placements and debt financings; joint ventures; and product development, licensing, supply and distribution arrangements.

Shartsis Friese provides clients the resources, support and sophistication of a large firm, with the personal service and agility of a small firm.  We provide experienced, senior-level support for our clients with a small, efficient team of dedicated lawyers.

Represented Waste Connections in hundreds of acquisitions with transaction sizes ranging from $1 million to over $600 million.

Represented Fermented Food Holdings in connection with purchase of Bubbies, Wildbrine and various sauerkraut brands.

Represented Teichert Inc. in $93.5 million acquisition of non-core concrete and aggregates assets from Eagle Materials

Represented Kelly-Moore Paint Company in connection with its sale to Flacks Group.

Represented beverage distributor in connection with a $115 million syndicated credit facility for acquisition finance.

Represented hedge fund on a $250 million syndicated credit facility.

Represented manufacturer on $300 million syndicated credit facility.

Represented educational institution on $20 million tax-free bond financing.

Represented real estate investment trust on a $200 million repurchase facility related to a mortgage loan portfolio.

Represented institutional asset manager on a $200 million repurchase facility related to entitlement and development of vacant land.

Represented medical device-maker on underwritten offering, PIPES and registered direct transactions.

Represented agricultural company on rights offering and take-down from shelf.

Represented healthcare company in first underwritten offering on Form S-1.

Represented software application company in connection with $7 million Series B financing round.

Represented lead investors in $2 million Series Seed investment in online subscription service company.